載入...
Intracellular targeted co-delivery of shMDR1 and gefitinib with chitosan nanoparticles for overcoming multidrug resistance
Nowadays, multidrug resistance and side effects of drugs limit the effectiveness of chemotherapies in clinics. P-glycoprotein (P-gp) (MDR1), as a member of the ATP-binding cassette family, acts on transporting drugs into cell plasma across the membrane of cancer cells and leads to the occurrence of...
Na minha lista:
| 發表在: | Int J Nanomedicine |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4648604/ https://ncbi.nlm.nih.gov/pubmed/26648717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S92436 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|